<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="original author and source are properly credited. Abstract Parasitic diseases" exact="plague" post="billions of people among the poorest, killing millions annually,"/>
 <result pre="urgent need for efficacious and cheap vaccines and treatments against" exact="visceral leishmaniasis" post="(VL), its most severe form. Several vaccination strategies have"/>
 <result pre="need for efficacious and cheap vaccines and treatments against visceral" exact="leishmaniasis" post="(VL), its most severe form. Several vaccination strategies have"/>
 <result pre="diseases are major causes of human disease and misery. They" exact="plague" post="billions of people among the poorest, killing millions annually,"/>
 <result pre="both the parasite species and the hostâ€™s immune response. Visceral" exact="leishmaniasis" post="(VL) is the most severe form of the disease"/>
 <result pre="70 000 deaths per year, thus ranking second only to" exact="malaria" post="for mortality and fourth for morbidity amongst tropical parasitic"/>
 <result pre="immunity associated to resistance to both human VL and canine" exact="leishmaniasis" post="(CanL) is associated to a skewed Th1-like immune response"/>
 <result pre="[25], [26], [27], [28], [29], [30], [31], including that of" exact="leishmaniasis" post="[32], [33], and vaccination [34], [35], [36], [37]. In"/>
 <result pre="Seroreactivity against rTRYP was not detected. Histopathology Findings compatible with" exact="leishmaniasis" post="â€&quot;follicular hyperplasia, mononuclear inflammatory infiltrate in the periportal areas,"/>
 <result pre="alterations in spleen and liver that have been attributed to" exact="leishmaniasis" post="in hamsters and dogs [40], [64]. Attempts to enhance"/>
 <result pre="Attempts to enhance the protective immune responses against experimental murine" exact="leishmaniasis" post="have been successful using HPB vaccination strategies based on"/>
 <result pre="potential of DNA, protein, and HPB vaccination was evaluated against" exact="leishmaniasis" post="in the murine model [68], [69]. Unfortunately, experimental models"/>
 <result pre="to allow comparisons. Valid surrogate markers of protection against human" exact="leishmaniasis" post="and in clinical bio-models are still lacking. The most"/>
 <result pre="clinical trial. Vet J179: 259â€&quot;263.18023375 9DyeC (1996) The logic of" exact="visceral leishmaniasis" post="control. Am J Trop Med Hyg55: 125â€&quot;130.8780448 10LeeBY, BaconKM,"/>
 <result pre="trial. Vet J179: 259â€&quot;263.18023375 9DyeC (1996) The logic of visceral" exact="leishmaniasis" post="control. Am J Trop Med Hyg55: 125â€&quot;130.8780448 10LeeBY, BaconKM,"/>
 <result pre="KitchenSB, ConnorDL, et al. (2012) The economic value of a" exact="visceral leishmaniasis" post="vaccine in Bihar state, India. Am J Trop Med"/>
 <result pre="ConnorDL, et al. (2012) The economic value of a visceral" exact="leishmaniasis" post="vaccine in Bihar state, India. Am J Trop Med"/>
 <result pre="HankeT, RodriguezD, RodriguezJR, et al. (2003) Protection in dogs against" exact="visceral leishmaniasis" post="caused by Leishmania infantum is achieved by immunization with"/>
 <result pre="RodriguezD, RodriguezJR, et al. (2003) Protection in dogs against visceral" exact="leishmaniasis" post="caused by Leishmania infantum is achieved by immunization with"/>
 <result pre="Heterologous prime-boost vaccination with the LACK antigen protects against murine" exact="visceral leishmaniasis." post="Infect Immun73: 5286â€&quot;5289.16041057 20RamosI, AlonsoA, MarcenJM, PerisA, CastilloJA, et"/>
 <result pre="non-replicative vaccinia recombinant vector expressing LACK confers protection against canine" exact="visceral leishmaniasis" post="with a predominant Th1-specific immune response. Vaccine26: 333â€&quot;344.18093705 21RamosI,"/>
 <result pre="vaccinia recombinant vector expressing LACK confers protection against canine visceral" exact="leishmaniasis" post="with a predominant Th1-specific immune response. Vaccine26: 333â€&quot;344.18093705 21RamosI,"/>
 <result pre="and II of Leishmania infantum confers protective immunity in murine" exact="visceral leishmaniasis." post="Vaccine24: 2169â€&quot;2175.16325969 23RafatiS, NakhaeeA, TaheriT, TaslimiY, DarabiH, et al."/>
 <result pre="TaslimiY, DarabiH, et al. (2005) Protective vaccination against experimental canine" exact="visceral leishmaniasis" post="using a combination of DNA and protein immunization with"/>
 <result pre="DarabiH, et al. (2005) Protective vaccination against experimental canine visceral" exact="leishmaniasis" post="using a combination of DNA and protein immunization with"/>
 <result pre="DuizerE, EscribanoJM, et al. (2009) Serological immunoassay for detection of" exact="hepatitis" post="E virus on the basis of genotype 3 open"/>
 <result pre="et al. (2011) Insect larvae biofactories as a platform for" exact="influenza" post="vaccine production. Protein Expr Purif79: 35â€&quot;43.21421054 38DuthieMS, RamanVS, PiazzaFM,"/>
 <result pre="PiazzaFM, ReedSG (2012) The development and clinical evaluation of second-generation" exact="leishmaniasis" post="vaccines. Vaccine30: 134â€&quot;141.22085553 39RequenaJM, SotoM, DoriaMD, AlonsoC (2000) Immune"/>
 <result pre="DNA vaccine is highly immunogenic but not protective against experimental" exact="visceral leishmaniasis." post="Infect Immun69: 4719â€&quot;4725.11447143 42PerezLE, ChandrasekarB, SaldarriagaOA, ZhaoW, ArteagaLT, et"/>
 <result pre="KenneckeH, SpeersC, WoodsR, et al. (2012) Tumor markers in metastatic" exact="breast cancer" post="subtypes: frequency of elevation and correlation with outcome. Ann"/>
 <result pre="SpeersC, WoodsR, et al. (2012) Tumor markers in metastatic breast" exact="cancer" post="subtypes: frequency of elevation and correlation with outcome. Ann"/>
 <result pre="4648â€&quot;4654.17606603 46GotoY, BogatzkiLY, BertholetS, ColerRN, ReedSG (2007) Protective immunization against" exact="visceral leishmaniasis" post="using Leishmania sterol 24-c-methyltransferase formulated in adjuvant. Vaccine25: 7450â€&quot;7458.17804125"/>
 <result pre="46GotoY, BogatzkiLY, BertholetS, ColerRN, ReedSG (2007) Protective immunization against visceral" exact="leishmaniasis" post="using Leishmania sterol 24-c-methyltransferase formulated in adjuvant. Vaccine25: 7450â€&quot;7458.17804125"/>
 <result pre="induces an innate immune response and confers protection from lethal" exact="influenza" post="virus infection in mice. J Immunol171: 1133â€&quot;1139.12874198 48AbeT, HemmiH,"/>
 <result pre="PLoS One6: e24108.21918683 52ColerRN, CarterD, FriedeM, ReedSG (2009) Adjuvants for" exact="malaria" post="vaccines. Parasite Immunol31: 520â€&quot;528.19691556 53BarderasMG, RodriguezF, Gomez-PuertasP, AvilesM, BeitiaF,"/>
 <result pre="production by peripheral blood mononuclear cells from cutaneous and mucosal" exact="leishmaniasis" post="patients. Scand J Immunol61: 337â€&quot;342.15853916 56SuffiaI, FerruaB, StienX, MograbiB,"/>
 <result pre="10 production by peripheral blood mononuclear cells of patients with" exact="visceral leishmaniasis." post="Infect Immun68: 630â€&quot;636.10639426 57MelbyPC, TryonVV, ChandrasekarB, FreemanGL (1998) Cloning"/>
 <result pre="cytokine cDNAs and analysis of cytokine mRNA expression in experimental" exact="visceral leishmaniasis." post="Infect Immun66: 2135â€&quot;2142.9573100 58HuygenK (2005) Plasmid DNA vaccination. Microbes"/>
 <result pre="IL-4 generation: evidence for mixed Th1- and Th2-like responses in" exact="visceral leishmaniasis." post="J Immunol174: 7160â€&quot;7171.15905560 61GomesR, TeixeiraC, TeixeiraMJ, OliveiraF, MenezesMJ, et"/>
 <result pre="a sand fly vector protects against the fatal outcome of" exact="visceral leishmaniasis" post="in a hamster model. Proc Natl Acad Sci U"/>
 <result pre="sand fly vector protects against the fatal outcome of visceral" exact="leishmaniasis" post="in a hamster model. Proc Natl Acad Sci U"/>
 <result pre="compartment associated with parasitism and serum biochemical changes in canine" exact="visceral leishmaniasis." post="Res Vet Sci84: 269â€&quot;277.17604064 65GonzaloRM, del RealG, RodriguezJR, RodriguezD,"/>
 <result pre="al. (2002) A heterologous prime-boost regime using DNA and recombinant" exact="vaccinia virus" post="expressing the Leishmania infantum P36/LACK antigen protects BALB/c mice"/>
 <result pre="expressing the Leishmania infantum P36/LACK antigen protects BALB/c mice from" exact="cutaneous leishmaniasis." post="Vaccine20: 1226â€&quot;1231.11803085 66LangeUG, MastroeniP, BlackwellJM, StoberCB (2004) DNA-Salmonella enterica"/>
 <result pre="DNA and recombinant ORFF protein confers protective immunity against experimental" exact="visceral leishmaniasis." post="J Infect Dis191: 2130â€&quot;2137.15898000 68RafatiS, GhaemimaneshF, ZahedifardF (2006) Comparison"/>
</results>
